GlassScriptPhysician profile
Lisa Collazzo
NPI 1821083270
$18,872.18
in general payments reported to CMS, 2019-2025
6 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2022: $645 · 2023: $13K · 2024: $4,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Honoraria: $4,300 · Travel and Lodging: $3,147 · Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,012.50 |
| Honoraria | $4,300.00 |
| Travel and Lodging | $3,147.41 |
| Food and Beverage | $543.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elucent Medical | $18,648.36 | 2022-2024 | |
| Puma Biotechnology, INC. | $94.92 | 2019 | |
| Eisai INC. | $49.79 | 2019 | |
| Celgene Corporation | $33.55 | 2019 | |
| Lilly USA, LLC | $33.06 | 2019 | |
| Amgen INC. | $12.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Collazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.